Inhibikase looks at infectious disease differently. The Company creates products that target the patient, not the pathogen. This approach blocks a virus (or a bacterium) from reproducing in the patient and stimulates the patient's immune system to fight future infections without administration of more of the Company product. Thus, Inhibikase's treatments treat the disease and prevent reoccurrence, improving overall health for patients. Several of the Company's products have the potential to fight multiple diseases simultaneously, like flu and pneumonia, smallpox and PML and they may enhance success of kidney and other organ transplants.
A key advantage of the Inhibikase approach is the focus on the patient. Blocking a common pathway in the patient avoids creating resistance to the Company's products. If fully realized, Inhibikase could actually create permanent solutions to common ailments that affect the every day lives of people. Our goal is a school year without colds or ear infections, flu or strep throat and vacations for relaxation, not convalescence.
|
